Table 2.
Pooled prevalence rate and 95% CI of antibiotic resistance of E. coli based on meta-analysis.
| Subgroup (Antibiotics) | Number of studies | Number of Ioslates | Prevalence % (95%CI) | I2 (%) | P-value |
|---|---|---|---|---|---|
| Ampicillin | 15 | 1186 | 0.694 (0.485–0.845) | 98.451 | 0.402 |
| Streptomycin | 7 | 122 | 0.094 (0.030–0.259) | 96.984 | 0.440 |
| Ceftazidime | 3 | 132 | 0.218 (0.015–0.834) | 97.553 | 0.301 |
| Cephalothin | 4 | 63 | 0.331 (0.060–0.794) | 96.735 | 0.500 |
| Penicillin | 3 | 349 | 0.934 (0.258–0.998) | 95.633 | 0.059 |
| Tetracycline | 12 | 500 | 0.402 (0.194–0.652) | 98.393 | 0.392 |
| Ciprofloxacin | 13 | 223 | 0.131 (0.058–0.271) | 96.360 | 0.232 |
| Cefuroxime | 3 | 101 | 0.305 (0.068–0.725) | 96.203 | 0.301 |
| Gentamicin | 9 | 204 | 0.154 (0.054–0.367) | 96.631 | 0.149 |
| Chloramphenicol | 7 | 83 | 0.082 (0.039–0.163) | 84.653 | 0.147 |
| Erythromycin | 3 | 168 | 0.923 (0.130–0.999) | 95.101 | 0.301 |
| Cefotaxime | 5 | 92 | 0.253 (0.062–0.633) | 96.679 | 0.164 |
| Cefaxitin | 4 | 88 | 0.441 (0.311–0.580) | 70.947 | 0.248 |
| Amikacin | 6 | 168 | 0.159 (0.032–0.516) | 97.865 | 0.425 |
| Nalidixic acid | 7 | 231 | 0.229 (0.114–0.407) | 95.158 | 0.325 |
| Amoxycillin-clavulanic acid | 6 | 213 | 0.402 (0.202–0.641) | 96.296 | 0.019 |
| Nitrofurantoin | 3 | 145 | 0.335 (0.075–0.757) | 97.239 | 0.301 |
| MDR | 12 | 642 | 0.507 (0.286–0.726) | 98.390 | 0.027 |
MDR: Multidrug resistant.